Document is current
Any future updates will be listed below
-
Authors
Zhang, Diana
Jahanfar, Shayesteh
Rabinowitz, Judy B.
Dower, Joshua
Song, Fei
Wu, Cherng-Horng
Hu, Xiao
Tracy, Phillip
Basik, Mark
Medford, Arielle
Lin, Po-Han
Huang, Chiun-Sheng
Bidard, Francois-Clement
Renault, Shufang
Pai, Lori
Buss, Mary
Parsons, Heather A.
Schlam, Ilana
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 23 February 2025
First Online: 12 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Parsons has served in advisory roles for AstraZeneca, Caris, Daiichi-Sankyo, Natera, Neogenomics, SAGA Diagnostics, and Sermonix. Her institution has also received research funding from Merck outside of the submitted work. Dr. Medford has served as an advisor/consultant for AstraZeneca, Guardant Health, Illumina, Myriad Genetics, Natera, SAGA Diagnostics, and Science for America, outside the submitted work. Her research is supported by a National Institutes of Health K12 grant (K12CA087723). Dr. Huang reports grants, personal fees and non-financial support from AstraZeneca, Daiichi-Sankyo, EirGenix, Eli Lilly, Novartis, Pfizer, Roche; grants and non-financial support from MSD, grants and personal fees from Gilead, grants from OBI Pharma, grants from Seagen, and grants from Aston Sci outside the submitted work. Dr. Bidard has served in advisory role for AstraZeneca, Daiichi-Sankyo, Lilly, Novartis, Roche, Foresight Diagnostics, Menarini Silicon Biosystems, SAGA Diagnostics.The following authors do not have any conflicts of interest to disclose: DZ, SJ, JR, JD, FS, CW, PT, XH, MBasik, SR, PHL, LP, MBuss, IS.
